Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Femoral artery Stories

2014-03-28 12:26:29

Supera Stent Addresses Growing Need in the U.S. to Treat People with Blocked Blood Vessels and Restore Blood Flow in the Upper Leg ABBOTT PARK, Ill., March 28, 2014 /PRNewswire/ -- Abbott today announced that its Supera(®) Peripheral Stent System has received U.S. Food and Drug Administration (FDA) approval to treat people with blocked blood vessels in the upper leg caused by peripheral artery disease (PAD). PAD occurs when fat and cholesterol buildup causes arteries outside of the...

2013-10-08 16:25:00

Study released at Vascular Interventional Advances scientific conference today KANSAS CITY, Mo., Oct. 8, 2013 /PRNewswire-USNewswire/ -- Data from a study led by researchers at Saint Luke's Mid America Heart Institute showed marked, long-term improvement in health status in patients suffering from peripheral artery disease treated with the S.M.A.R.T. Nitinol Self-Expandable Stent. The study was sponsored by Cordis Corporation, (Fremont, Calif.), manufacturer of the S.M.A.R.T....

Taking Pulse From The Finger Can Show Aorta Stiffness
2013-09-05 17:09:25

Enid Burns for redOrbit.com – Your Universe Online An academic from the University of Iowa has developed a new, simpler method to measure the stiffness of the aorta, a common risk factor of heart disease. The new method uses an instrument called a transducer on the finger, or over the brachial artery just inside the arm beneath the elbow. Measuring the pulse, combined with factors, including a person's age and body mass index, enables the doctor to determine whether the aorta has...

2013-06-11 11:22:38

Study Highlights: -Opening clogged heart arteries via the radial artery in the wrist is becoming more common. -The wrist route may have fewer complications than the traditional route through the femoral artery in the groin. -Use of the procedure increased 13-fold in a six-year period. The way to a man´s heart may be his wrist. More U.S. doctors are unclogging heart arteries (in men and women) by entering through the radial artery in the wrist, which is linked to less bleeding...

2013-01-24 16:26:39

WEBSTER, Texas and LEIPZIG, Germany, Jan. 24, 2013 /PRNewswire/ -- At the Leipzig Interventional Course (LINC) in Leipzig, Germany, physicians from the United States and Europe presented data on their clinical experience with the IDEV Technologies Supera® stent. LINC is a meeting forum of global interdisciplinary physicians focusing on endovascular peripheral interventional treatments. Results on over 1,000 treated patients were compiled and presented, including findings from...

2012-10-22 19:20:59

MIAMI and WEBSTER, Texas, Oct. 22, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced the presentation of consistent positive clinical outcomes of the SUPERA® Peripheral Stent System from its SUPERB pivotal U.S. clinical trial and SUPERA 500 long-term registry conducted in Germany. IDEV's data confirms a robust and consistent growing body of clinical evidence for SUPERA's highly differentiated, disruptive and proprietary stent design. The presentation was...

2012-10-10 19:23:02

LAS VEGAS and WEBSTER, Texas, Oct. 10, 2012 /PRNewswire/ -- IDEV Technologies, Inc. (IDEV) today announced positive clinical outcomes for its SUPERB pivotal clinical trial of its SUPERA® Peripheral Stent System. This Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial demonstrated the highest patency rates in peripheral stent trials for superficial femoral or proximal popliteal artery disease that has been publically reported. In addition, this is the first and...

2012-07-11 02:26:00

CAESAREA, Israel, July 11, 2012 /PRNewswire/ -- Angioslide Ltd., a provider of Embolic Capture Angioplasty solutions, today announced the successful deployment of a 3X100mm PROTEUS device for treating Peripheral Artery Disease in below-the-knee (BTK) vasculature at Community Hospital in Munster, IN. Accommodating a 0.014" guide-wire, the new device allows physician to perform a PTA revascularization in BTK vessels while capturing and removing embolic particles. "With...

2011-11-14 11:14:33

In patients with diabetes, cryoplasty post-dilation compared to conventional balloon angioplasty decreases the risk of in-stent restenosis of the superficial femoral artery A clinical trial of patients with diabetes has demonstrated that cryoplasty post-dilitation compared to conventional balloon angioplasty in the superficial femoral artery (SFA) decreased the risk of in-stent restenosis (ISR). Results from the COBRA clinical trial were presented today at the 23rd Annual Transcatheter...

2011-05-16 07:33:00

REDWOOD CITY, Calif., May 16, 2011 /PRNewswire/ -- Arstasis is pleased to announce the U.S. launch of its latest commercial product - the AXERA(TM) Access Device. The AXERA Device enhances insertability into the femoral artery and overall procedural usage while continuing to deliver the clinical benefits of the implant-free Arstaotomy Procedure. Since 1959, physicians have been using the Modified Seldinger Technique for femoral artery access. At the end of every such case, patients are...